Navigation Links
Promise for Treating Low Back Pain - Radiofrequency a Trusted Technique With a New Application
Date:6/23/2009

WILMINGTON, Mass., June 23 /PRNewswire/ -- Who suffers from low back pain; my brother, my boss's brother, my neighbor, a friend on the golf course and recently the media reports Regis Philbin and Jeff Gordon suffer from low back pain.

(Logo: http://www.newscom.com/cgi-bin/prnh/20090217/NE70925LOGO )

Sacroiliac Pain is caused by inflammation or abnormal function of the joint which can lead to sacral nerve damage, and is a major cause of low back pain. Low back pain is estimated to affect 6.5 million people in the world. Now Simplicity lll, a new radiofrequency electrode, offers an alternative and possibly longer lasting relief from a common affliction. Radiofrequency is a widely used and effective treatment for certain chronic pain conditions, and using RF technology NeuroTherm introduces a new treatment option to address some instances of low back pain.

"There is a new technology available to treat patients with Sacroiliac Pain," says Dr. Gregory Paine from Naples Day Surgery North (www.gregpainemd.com). Paine was one of twelve physicians nationally, and the first in Florida, initially trained on the new medical device Simplicity lll, which was designed specifically for use in treating sacroiliac peripheral nerves. "This technology represents a tremendous breakthrough in giving patients long lasting relief for one of the more common causes of low back pain," continues Paine.

Laurence Hicks, CEO of NeuroTherm the manufacturer of Simplicity lll, is a 20+ year participant in the medical device industry. "Simplicity lll is as revolutionary and promising a device as I have seen in my career, and we need to make the treatment accessible to the many suff
'/>"/>

SOURCE NeuroTherm, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Novel light-sensitive compounds show promise for cancer therapy
2. Study shows promise for new cancer-stopping therapy
3. Reduced-Radiation Heart Scans Dont Compromise on Quality
4. New Diabetes Drug Shows Promise in Trial
5. Vaporized viral vector shows promise in anti-cancer gene therapy
6. Vaccine shows therapeutic promise against advanced melanoma
7. Immune-Based Lymphoma Treatment Shows Promise
8. Tool Shows Promise for Measuring Productivity of Mid-Level Oncology Providers
9. Small molecule inhibitor shows promise in trastuzumab-resistant metastatic breast cancer
10. Cottonseed-based drug shows promise in treating severe brain cancer
11. Oral Health Should Never Be Compromised
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2009)... popping up in the most unusual places, and to do ...keeping prisoners in jail! , ...ught that your wine, water and vegetables would ha...h, Texas has announced a new line of turbines, for...hnology developed to provide power for dairies in ...
(Date:12/4/2009)...st Inc. (NYSE: CRE ) ("Care" or the "Company") ...clared a dividend of $0.17 per share of common sto...to common shareholders of record on December 14, 2...nvestment Trust Inc. is a real estate investment a... real estate and commercial mortgage debt. It is ...
(Date:12/4/2009).... has won the Patient,s Choice Award as the favori...onducted by the online website, www.weedmaps.com....ay community has selected Medithrive as the preemi... ,, The rapid rise and popularity of Medithrive co...he consumer, provides a beautiful environment with...
(Date:12/4/2009)...iation of Homes and Services for the Aging (AAHSA)...ity Living and Supportive Services (CLASS) provisi.... The CLASS provisions are essential for providing...heir caregivers. ,, We urge the Senate to pass a ...le to care for families and caregivers. , , SOURC...
(Date:12/4/2009)... two-day free health clinic sponsored by the Natio...ity on Wednesday and Thursday is not just for the ...not seen a doctor recently. All participants in th...re. ,, "Many people who attended the three previo...New Orleans and Little Rock found out they had hea...
Breaking Medicine News(10 mins):Health News:Distributor Announces New Applications for Wind Turbines 2Health News:Distributor Announces New Applications for Wind Turbines 3Health News:Care Investment Trust Inc. Declares Quarterly Dividend of $0.17 Per Share 2Health News:Free Health Clinic Event Is Not Just for the Sick 2
..., Jan. 28 NutraCea (OTC Bulletin,Board: NTRZ), a ...nt,research and technology, today provided an upda...d that its Stage Two facility located in Dillon,Mo...ing. Further, the facility is fully committed to r...
...rence Call Today at 4:30 p.m. Eastern Time -, SAN...VN ) today announced that, based on its end-of-Pha...ation (FDA), the Company plans to,begin a pivotal ...he company,s previously completed,trial conducted ...
... Provides Users with Insight into Pharmaceutical I... Media Trends, NEW YORK, Jan. 28 Manhattan Resea... services for the health and,pharmaceutical indust...S. consumers includes trended data for over five,y...
... PRUSSIA, PA, Jan. 28 /PRNewswire-FirstCall/ - MDS... drug discovery and development,solutions, has est...e,expanded capabilities in global clinical trial m...a Pacific, Europe, Latin,America and North America...
...STER, Colo., Jan. 28 Allos,Therapeutics, Inc. (Na...ruce,K. Bennett as Vice President, Manufacturing. ...y,s manufacturing functions to support the continu...ent and CEO. "Bruce,s experience in all aspects of...
...ssy, is a soldier in the battle against pancreatic...ancer deaths in the U.S., BETHPAGE, N.Y., Jan. 28...ssy" Bonpensiero on the Emmy Award winning series,...ce," with Donald "The Donald" Trump., Pastore won...
Other Medicine News:Health News:NutraCea Provides Update on Domestic Operations 2Health News:NutraCea Provides Update on Domestic Operations 3Health News:Medivation Plans to Initiate Pivotal Confirmatory Phase 3 Trial of Dimebon(TM) for Alzheimer's Disease in Second Quarter of 2008 2Health News:Medivation Plans to Initiate Pivotal Confirmatory Phase 3 Trial of Dimebon(TM) for Alzheimer's Disease in Second Quarter of 2008 3Health News:Manhattan Research: ePharma Consumer(R) Research and Advisory Service Now Available 2Health News:MDS Pharma Services Expands Presence in Latin America with Sao Paulo Office 2Health News:MDS Pharma Services Expands Presence in Latin America with Sao Paulo Office 3Health News:Allos Therapeutics Appoints Bruce K. Bennett as Vice President, Manufacturing 2Health News:Allos Therapeutics Appoints Bruce K. Bennett as Vice President, Manufacturing 3
(Date:12/4/2009)...c. 4 Oxygen Biotherapeutics, Inc. (OTC Bulletin B... has been enrolled in the company,s Phase II-b, do...se of Oxycyte(TM) emulsion in traumatic brain inju... (PFC) therapeutic oxygen carrier. ,, "This trial ...me of patients with severe TBI. We hope to finally...
(Date:12/4/2009)...FOREST, Ill., Dec. 4 Hospira, Inc. (NYSE: HSP )...dication delivery company, today announced the lau...TM) containers for intravenous (I.V.) medications ...e (50 mL to 1 L) of the award-winning, environment...50 mL and 100 mL containers follows the launch of ...
(Date:12/4/2009)...HOUSTON, Dec. 4 OrthoAccel Technologies, Inc., de...cceleration device to enhance orthodontics, announ... course published by PennWell Corporation , a lea... including medicine and dentistry. The course foc... a summary of treatment biomechanics, factors that...
Breaking Medicine Technology:Oxygen Biotherapeutics, Inc. Enrolls First Patient in Traumatic Brain Injury Clinical Trial in Switzerland 2Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 2Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 3Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 4AcceleDent Science is Showcased in New Continuing Education Course Published by PennWell 2AcceleDent Science is Showcased in New Continuing Education Course Published by PennWell 3AcceleDent Science is Showcased in New Continuing Education Course Published by PennWell 4Brown and beige dominate the plate 3A Daily dose of color needed to fill Americas phytonutrient gap 10372 1Brown and beige dominate the plate 3A Daily dose of color needed to fill Americas phytonutrient gap 10372 2Brown and beige dominate the plate 3A Daily dose of color needed to fill Americas phytonutrient gap 10372 3Brown and beige dominate the plate 3A Daily dose of color needed to fill Americas phytonutrient gap 10372 4Graffinity Enters into Drug Discovery Research Collaboration with Genentech 10370 1Graffinity Enters into Drug Discovery Research Collaboration with Genentech 10370 2Bug barcode readers hold out promise of universal vaccines 10368 1Bug barcode readers hold out promise of universal vaccines 10368 2
Liquichek CK/LD Isoenzyme Control
Lyphochek Diabetes Control
Liquichek Sedimentation Rate Control
Liquichek ToRCH Plus IgM Controls
Medicine Products: